Trial Profile
A Randomized, Double Blind, Placebo Controlled Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation to Explore the Tolerance, Safety and Pharmacokinetic Characteristics in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs SSS 07 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Shenyang Sunshine Pharmaceutical
- 24 Dec 2017 Status changed from recruiting to completed.
- 11 Jun 2015 New trial record